Manchester Capital Management LLC Procept Bio Robotics Corp Transaction History
Manchester Capital Management LLC
- $829 Million
- Q3 2024
A detailed history of Manchester Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Manchester Capital Management LLC holds 37 shares of PRCT stock, worth $3,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37Holding current value
$3,097% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$405 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$292 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$128 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$104 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$98.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.73B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...